Mutant phenotypes.
- Andrew S. Houppert (174210)
- Elizabeth Kwiatkowski (174220)
- Elizabeth M. Glass (11353)
- Kristin L. DeBord (174237)
- Peter M. Merritt (174244)
- Olaf Schneewind (53207)
- Melanie M. Marketon (174257)
Publication date
March 2012
DOIAbstract
a<p>In vitro growth curves were done using Heart Infusion Broth.</p>b<p>Median survival was calculated based on infections with WT at 10<sup>5</sup> cfu, the <i>ctgA</i> mutant at 10<sup>7</sup> cfu, or the <i>rfaL</i> mutant at 10<sup>7</sup> cfu. No deaths occurred during infections with other mutants, so survival times are not indicated (ND).</p
Add to ORKG